Nevirapine is predicted to increase the metabolism of ergot derivatives, and might therefore be expected to reduce their efficacy. Monitor the outcome of concurrent use to ensure the effects of ergot derivatives are adequate.
(17)
This site is intended for general information only. The information provided on this site does not constitute medical advice and should not be relied upon. You should not act or refrain from acting on any legal or medical matter based on the content of this site.